Pharmaxis Ltd - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Pharmaxis Ltd. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Pharmaxis Ltd. The Group's principal activities are researching, developing and commercializing human healthcare products for the treatment and management of chronic respiratory and immune disease. Products include Aridol and Bronchitol. Aridol is designed to help doctors diagnose and manage asthma by detecting active airway inflammation through measuring airway hyper-responsiveness. Bronchitol is a drug designed to reduce the amount of mucus build-up in the lungs of patients suffering from chronic respiratory conditions. The Group operates predominantly in Australia.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report